Q. Shao

Safety and efficacy of vildagliptin versus placebo in patients with type 2 diabetes and moderate or severe renal impairment: a prospective 24‐week randomized placebo‐controlled trial

Valentina Lukashevich, Anja Schweizer, Q. Shao et al. · Diabetes Obesity and Metabolism · 2011 · 146 citations

One‐year safety, tolerability and efficacy of vildagliptin in patients with type 2 diabetes and moderate or severe renal impairment

Wolfgang Kothny, Q. Shao, Per‐Henrik Groop et al. · Diabetes Obesity and Metabolism · 2012 · 103 citations

Clinical experience with vildagliptin in the management of type 2 diabetes in a patient population ≥75 years: a pooled analysis from a database of clinical trials

Anja Schweizer, S. Dejager, James E. Foley et al. · Diabetes Obesity and Metabolism · 2010 · 102 citations

Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus

Wolfgang Kothny, James E. Foley, Plamen Kozlovski et al. · Diabetes Obesity and Metabolism · 2012 · 99 citations

Efficacy and Safety of Vildagliptin Monotherapy during 2-Year Treatment of Drug-naïve Patients with Type 2 Diabetes: Comparison with Metformin

Burkhard Göke, Kenneth S. Hershon, Douglas A. Kerr et al. · Hormone and Metabolic Research · 2008 · 92 citations